Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Mainland China Revenue	21.40B	25.11B	27.18B
Mainland China Revenue Growth	-14.75%	-7.64%	4.00%
Other Asian Regions Revenue	1.20B	1.18B	1.58B
Other Asian Regions Revenue Growth	1.57%	-25.31%	-8.80%
North America Revenue	1.38B	853.04M	881.80M
North America Revenue Growth	61.28%	-3.26%	-25.03%
Europe Revenue	1.41B	1.31B	1.28B
Europe Revenue Growth	7.70%	2.85%	0.70%
Other Geographies Revenue	604.24M	553.88M	524.83M
Other Geographies Revenue Growth	9.09%	5.54%	-15.01%

Revenue

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Nervous System Revenue	8.16B	9.65B	9.09B
Nervous System Revenue Growth	-15.36%	6.12%	12.10%
Oncology Revenue	2.77B	4.40B	6.14B
Oncology Revenue Growth	-37.10%	-28.33%	-16.36%
Anti-Infectives Revenue	3.44B	4.09B	4.24B
Anti-Infectives Revenue Growth	-15.91%	-3.54%	19.66%
Cardiovascular Revenue	1.72B	2.08B	2.44B
Cardiovascular Revenue Growth	-17.35%	-14.79%	-15.54%
Respiratory System Revenue	1.02B	1.20B	1.56B
Respiratory System Revenue Growth	-15.06%	-23.14%	124.14%
Digestion and Metabolism Revenue	932.10M	1.05B	889.00M
Digestion and Metabolism Revenue Growth	-11.31%	18.22%	17.75%
Other Therapeutic Areas Revenue	1.31B	1.26B	1.25B
Other Therapeutic Areas Revenue Growth	3.80%	0.72%	24.15%
Total Finished Drugs Revenue	19.34B	23.72B	25.60B
Total Finished Drugs Revenue Growth	-18.45%	-7.36%	5.21%
Vitamin C Revenue	2.21B	1.99B	1.93B
Vitamin C Revenue Growth	10.64%	3.36%	-23.71%
Antibiotics Revenue	1.60B	1.59B	1.71B
Antibiotics Revenue Growth	0.48%	-7.19%	13.91%
Total Bulk Products Revenue	3.80B	3.58B	3.64B
Total Bulk Products Revenue Growth	6.14%	-1.60%	-9.69%
Licence Fee Income	1.09B	17.83M	34.70M
Licence Fee Income Growth	6026.96%	-48.61%	-81.33%
Functional Food and Others Revenue	1.76B	1.69B	2.17B
Functional Food and Others Revenue Growth	4.18%	-22.18%	-8.94%

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Finished Drugs Segment Profit	3.73B	4.83B	6.70B
Finished Drugs Segment Profit Growth	-22.70%	-27.94%	10.42%
Vitamin C Segment Profit	324.64M	211.28M	4.95M
Vitamin C Segment Profit Growth	53.65%	4168.26%	-98.88%
Antibiotics Segment Profit	258.20M	299.18M	154.35M
Antibiotics Segment Profit Growth	-13.69%	93.83%	35.21%
Total Bulk Products Segment Profit	582.84M	510.45M	159.30M
Total Bulk Products Segment Profit Growth	14.18%	220.44%	-71.39%
Functional Food and Others Segment Profit	339.79M	305.29M	561.53M
Functional Food and Others Segment Profit Growth	11.30%	-45.63%	-13.27%

Updated Jun 30, 2025. Data Source: Fiscal.ai.